healthcare
healthcare Articles
Denali Therapeutics announced early Thursday that it would be progressing its Parkinson’s treatment into late-stage studies in collaboration with Biogen.
Published:
Novavax shares hit another all-time high on Wednesday after the company announced positive results from its early stage COVID-19 vaccine study.
Published:
24/7 has compiled a few biopharmaceutical names that have lagged the markets and recently have reported earnings. In a sense, the fundamentals have shown some light on these stocks, that they may be...
Published:
Pharmacy and health insurer CVS handily beat expected earnings and revenue estimates for the second quarter.
Published:
Regeneron Pharmaceuticals, one of the front-runners for the development of a COVID-19 treatment, released an update on its antibody drug combination on Monday.
Published:
Alterity Therapeutics stock more than doubled on Tuesday after the company announced new data for its lead drug candidate for the treatment of multiple system atrophy.
Published:
Amarin reported its latest quarterly results on Tuesday morning and gave an update on the most recent developments with its blockbuster drug Vascepa.
Published:
CymaBay Therapeutics posted a huge gain to start off the week after the company reported results from a late-stage clinical study for the treatment of primary biliary cholangitis.
Published:
GW Pharmaceuticals shares popped early on Monday morning after the company announced that it received a key approval from the FDA for Epidiolex to treat certain seizures.
Published:
When Merck & Co. (NYSE: MRK) reported its second-quarter financial results before the markets opened on Wednesday, the pharmaceutical giant said that it had earnings per share (EPS) of $1.37 and...
Published:
Johnson & Johnson has announced that it will launch its human study for its lead vaccine candidate in the United States and Belgium.
Published:
Edesa Biotech joins the list of COVID-19 stocks, as the company is making headway with regulatory agencies for its late-stage study. Investors were quick to give this firm the coronavirus bump, more...
Published:
Spectrum Pharmaceuticals announced good news for lung cancer patients in its midstage trial on Tuesday.
Published:
Credit Suisse has assembled its favorite health care recovery stocks for a recovering base of elective surgeries and for the risk of rising hospitalizations that go well beyond COVID-19.
Published:
Pfizer released a better than expected second-quarter earnings report and increased its guidance before the markets opened on Tuesday.
Published: